A Family of four playing outdoors in the grass and sunshine

Healthier Communities

Creating Healthier Communities that Benefit all

Meeting the needs of people, patients and communities is the reason we exist. From developing new, innovative therapies for diseases to enabling greater access to life-saving vaccines, protecting the health and wellbeing of our patients and communities around the world sits at the center of our purpose as a business. This includes a heartfelt commitment to the safety and trust of our donors, who make vital therapies possible, and to continuous engagement with the stakeholders we depend upon to fulfill our promise.

CSL understands that when it aligns its efforts with core expertise and business goals, addressing priority focus areas and material topics in the context of the business and the industry, it can have the greatest positive impact. CSL has continued to evolve its sustainability strategy, with the goal of deploying its resources to service stakeholders in the focus areas of Access and Affordability, Patient Experience and Donor Experience.

This is CSL’s commitment to ‘Healthier Communities’, because it recognises that healthier communities benefit all.
CSL’s healthier communities focus areas and commitments include:

Focus Area Commitments 
Access and Affordability CSL is committed to advancing equitable access to its medicines and vaccines by designing access and affordability programs to serve vulnerable populations and expand strategic donations:

  • Through extension of CSL’s existing World Federation of Haemophilia (WFH) partnership, by FY2030, CSL aims to donate products that enable 2,100 people with bleeding disorders to access prophylaxis therapy across 25 low- and middle-income countries.
  • In support of reaching more communities and patients, through discounted products, CSL has announced a new aspirational commitment to treat up to 450,000 people with anaemia in at least three low- and middle-income countries with CSL Vifor’s Ferinject® by FY2030.
Patient Experience CSL’s commitment is to elevate the Patient Experience in drug development by embedding patient insights and lived experience through patient-informed clinical development programs and formalising plans to include representative populations.
CSL’s commitment for FY2030:

  • Informed Product Development: all of CSL’s therapeutic product development programs are informed by patient insights.
  • Representative Clinical Trials: Phase III clinical trials incorporate participants that are representative of the target indicated population.
Donor Experience CSL’s ambition is to create best-in-class donor experience in partnership with donors and communities, by continuously innovating the donation process, supporting donors’ holistic well-being, and investing in the health equity of donor communities.

CSL’s commitment for FY2030 is to initiate new programs to promote health awareness resources, ensuring that at least 30% of donors obtain access.

Furthermore, CSL intends to increase donor satisfaction survey results, utilising a new customer satisfaction methodology to be implemented and baselined in FY25.

CSL's Community Contributions Framework

Focus Area Focus Area Description Alignment with our Values and 2030 Strategy
Support for Patient Communities
  • Enhancing quality of life for patients in the conditions our therapies treat
  • Improving access to our medicines
  • Aligns with CSL’s Values of Patient Focus and Integrity.
  • Supports CSL’s Patient and Public Health and Focus strategic objectives by improving patient outcomes.
Support for Innovation and Science
  • Advancing knowledge in medical and scientific communities
  • Fostering the next generation of medical researchers
  • Aligns with CSL’s Values of Innovation and Collaboration.
  • Supports CSL’s Innovation strategic objective by fueling new breakthroughs, enhancing scientific knowledge and building capability and capacity.
Support for Local Communities
  • Supporting community efforts where we live and work
  • Supporting communities in times of emergency
  • Aligns with CSL’s Value of Superior Performance.
  • Supports CSL’s People and Culture strategic objective by creating an environment that employees feel proud to perform within.

Our approach to community contributions is guided by our Code of Responsible Business Practice and Global Community Contributions Policy. The policy applies to all CSL businesses and employees and is intended to be implemented across the businesses to guide decision-making and management of any form of community contribution, financial or by other means.